{"type":"rich","version":"1.0","title":"Can GLP-1 Therapy Revolutionize Chronic Skin Treatment?","description":"In this episode, board-certified dermatologist of US Dermatology Partners, Daniel Walker, MD, FAAD, shares emerging insights into the expanding role of GLP-1 receptor agonists beyond their primary use in diabetes and weight loss, highlighting their promising—yet still investigational—impact on inflammatory skin diseases such as psoriasis and HS.","author_name":"The Cutaneous Connection","author_url":"https://audioboom.com/channels/5027143-the-cutaneous-connection","provider_name":"Audioboom","provider_url":"https://audioboom.com","width":480,"height":95,"thumbnail_url":"https://audioboom.com/i/40755852/600x600/c","thumbnail_width":600,"thumbnail_height":600,"html":""}